- Home
- ABSI vs DIAX Comparison
ABSI vs DIAX Comparison
Compare ABSI & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABSI | DIAX |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 577.4M | 553.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABSI | DIAX |
|---|---|---|
| Price | $4.02 | $15.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $7.98 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 96.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,815,000.00 | N/A |
| Revenue This Year | $10.72 | N/A |
| Revenue Next Year | $437.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.01 | $12.80 |
| 52 Week High | $6.33 | $15.12 |
Technical Indicators
Market Signals| Indicator | ABSI | DIAX |
|---|---|---|
| Relative Strength Index (RSI) | 63.76 | 70.88 |
| Support Level | $3.40 | $15.10 |
| Resistance Level | $3.79 | $15.38 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 86.75 | 91.67 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.